| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99199 |
Unlisted special service, procedure or report |
57,219 |
33,659 |
$274K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,107 |
5,900 |
$187K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,099 |
1,978 |
$110K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
458 |
332 |
$21K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
1,378 |
737 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
672 |
444 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
129 |
126 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
395 |
236 |
$8K |
| 20610 |
|
486 |
260 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
702 |
334 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
611 |
326 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
796 |
284 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
188 |
152 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,204 |
599 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
502 |
216 |
$2K |
| 99442 |
|
73 |
45 |
$2K |
| 90686 |
|
534 |
302 |
$2K |
| 81001 |
|
1,356 |
821 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
379 |
257 |
$928.79 |
| 99215 |
Prolong outpt/office vis |
26 |
12 |
$732.38 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
384 |
221 |
$650.36 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
58 |
36 |
$396.20 |
| 97597 |
|
20 |
12 |
$186.61 |
| 73560 |
|
41 |
24 |
$180.36 |
| 73562 |
|
14 |
14 |
$145.03 |
| 99497 |
|
24 |
14 |
$116.76 |
| 73565 |
|
42 |
27 |
$115.70 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
32 |
20 |
$104.16 |
| 36415 |
Collection of venous blood by venipuncture |
191 |
166 |
$101.68 |
| 81003 |
|
71 |
53 |
$42.43 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
36 |
35 |
$25.79 |
| 3078F |
|
41 |
40 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
1,469 |
1,085 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
22 |
12 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
286 |
161 |
$0.00 |
| 99441 |
|
120 |
54 |
$0.00 |
| 3074F |
|
15 |
14 |
$0.00 |
| 3044F |
|
19 |
13 |
$0.00 |